U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT07575230) titled 'Suzetrigine vs Norco-PostOp Mohs Pain' on May 04.
Brief Summary: To compare suzetrigine versus hydrocodone/acetaminophen for postoperative pain control following dermatologic surgery.
Study Start Date: Nov. 03, 2025
Study Type: INTERVENTIONAL
Condition:
Cutaneous Tumors
Mohs Micrographic Surgery
Intervention:
DRUG: Norco 5Mg-325Mg Tablet
Standard of care drug
DRUG: Suzetrigine
Control Drug
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: Baylor Research Institute
Disclaimer: Curated by HT Syndication....